Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Journal of Visualized Experiments : Jove|September 29, 2025
Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell LymphomaJulia Thiel, Jan A Schlegel, Sam Steinfeldt, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 8, 2023
Toward model-informed precision dosing for tamoxifen: A population-pharmacokinetic model with a continuous CYP2D6 activity scaleBram C Agema, Sanne M Buijs, Sebastiaan D T Sassen, et al.
British Journal of Pharmacology|May 30, 2020
Subunits of BK channels promote breast cancer development and modulate responses to endocrine treatment in preclinical modelsCorinna J Mohr, Werner Schroth, Thomas E Mürdter, et al.
Clinical Pharmacokinetics|November 22, 2007
Role of p-glycoprotein inhibition for drug interactions: evidence from in vitro and pharmacoepidemiological studiesSonja Eberl, Bertold Renner, Antje Neubert, et al.
International Journal of Molecular Sciences|December 11, 2025
Feasibility of Patient-Derived 3D Gastrointestinal Stromal Tumour Models as Alternatives for In Vivo Mouse ModelsDina Mönch, Julia Thiel, Meng Dong, et al.
Journal of Personalized Medicine|April 23, 2022
(Z)-Endoxifen and Early Recurrence of Breast Cancer: An Explorative Analysis in a Prospective Brazilian StudyThais Almeida, Werner Schroth, Jeanine Nardin, et al.
Cell Death and Differentiation|May 21, 2020
Stress-induced TRAILR2 expression overcomes TRAIL resistance in cancer cell spheroidsDaniela Stöhr, Jens O Schmid, Tobias B Beigl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2025
Supplementation of Tamoxifen with Low-Dose Endoxifen in Patients with Breast Cancer with Impaired Tamoxifen Metabolism (TAMENDOX): A Randomized Controlled Phase I/II TrialThomas E Mürdter, Werner Schroth, Matthew P Goetz, et al.
Pageof 7